228 related articles for article (PubMed ID: 22504882)
1. Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation.
Musille PM; Pathak M; Lauer JL; Hudson WH; Griffin PR; Ortlund EA
Nat Struct Mol Biol; 2012 Apr; 19(5):532-S2. PubMed ID: 22504882
[TBL] [Abstract][Full Text] [Related]
2. Unexpected Allosteric Network Contributes to LRH-1 Co-regulator Selectivity.
Musille PM; Kossmann BR; Kohn JA; Ivanov I; Ortlund EA
J Biol Chem; 2016 Jan; 291(3):1411-26. PubMed ID: 26553876
[TBL] [Abstract][Full Text] [Related]
3. Integrated Structural Modeling of Full-Length LRH-1 Reveals Inter-domain Interactions Contribute to Receptor Structure and Function.
Seacrist CD; Kuenze G; Hoffmann RM; Moeller BE; Burke JE; Meiler J; Blind RD
Structure; 2020 Jul; 28(7):830-846.e9. PubMed ID: 32433991
[TBL] [Abstract][Full Text] [Related]
4. A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects.
Lee JM; Lee YK; Mamrosh JL; Busby SA; Griffin PR; Pathak MC; Ortlund EA; Moore DD
Nature; 2011 May; 474(7352):506-10. PubMed ID: 21614002
[TBL] [Abstract][Full Text] [Related]
5. Structure and Dynamics of the Liver Receptor Homolog 1-PGC1
Mays SG; Okafor CD; Tuntland ML; Whitby RJ; Dharmarajan V; Stec J; Griffin PR; Ortlund EA
Mol Pharmacol; 2017 Jul; 92(1):1-11. PubMed ID: 28363985
[TBL] [Abstract][Full Text] [Related]
6. Divergent sequence tunes ligand sensitivity in phospholipid-regulated hormone receptors.
Musille PM; Pathak M; Lauer JL; Griffin PR; Ortlund EA
J Biol Chem; 2013 Jul; 288(28):20702-12. PubMed ID: 23737522
[TBL] [Abstract][Full Text] [Related]
7. Crystal Structures of the Nuclear Receptor, Liver Receptor Homolog 1, Bound to Synthetic Agonists.
Mays SG; Okafor CD; Whitby RJ; Goswami D; Stec J; Flynn AR; Dugan MC; Jui NT; Griffin PR; Ortlund EA
J Biol Chem; 2016 Dec; 291(49):25281-25291. PubMed ID: 27694446
[TBL] [Abstract][Full Text] [Related]
8. Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP.
Ortlund EA; Lee Y; Solomon IH; Hager JM; Safi R; Choi Y; Guan Z; Tripathy A; Raetz CR; McDonnell DP; Moore DD; Redinbo MR
Nat Struct Mol Biol; 2005 Apr; 12(4):357-63. PubMed ID: 15723037
[TBL] [Abstract][Full Text] [Related]
9. Interleukin enhancer-binding factor 3 functions as a liver receptor homologue-1 co-activator in synergy with the nuclear receptor co-activators PRMT1 and PGC-1α.
Ohno M; Komakine J; Suzuki E; Nishizuka M; Osada S; Imagawa M
Biochem J; 2011 Aug; 437(3):531-40. PubMed ID: 21554248
[TBL] [Abstract][Full Text] [Related]
10. Structural and biochemical basis for selective repression of the orphan nuclear receptor liver receptor homolog 1 by small heterodimer partner.
Li Y; Choi M; Suino K; Kovach A; Daugherty J; Kliewer SA; Xu HE
Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9505-10. PubMed ID: 15976031
[TBL] [Abstract][Full Text] [Related]
11. Structure of Liver Receptor Homolog-1 (NR5A2) with PIP3 hormone bound in the ligand binding pocket.
Sablin EP; Blind RD; Uthayaruban R; Chiu HJ; Deacon AM; Das D; Ingraham HA; Fletterick RJ
J Struct Biol; 2015 Dec; 192(3):342-348. PubMed ID: 26416531
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferation activity of a small molecule repressor of liver receptor homolog 1.
Corzo CA; Mari Y; Chang MR; Khan T; Kuruvilla D; Nuhant P; Kumar N; West GM; Duckett DR; Roush WR; Griffin PR
Mol Pharmacol; 2015 Feb; 87(2):296-304. PubMed ID: 25473120
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulation study for LRH-1: interaction with fragments of SHP and function of phospholipid ligand.
Zhang T; Zhou JH; Shi LW; Zhu RX; Chen MB
Proteins; 2008 Mar; 70(4):1527-39. PubMed ID: 17910058
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism for the potentiation of the transcriptional activity of human liver receptor homolog 1 by steroid receptor coactivator-1.
Xu PL; Liu YQ; Shan SF; Kong YY; Zhou Q; Li M; Ding JP; Xie YH; Wang Y
Mol Endocrinol; 2004 Aug; 18(8):1887-905. PubMed ID: 15143151
[TBL] [Abstract][Full Text] [Related]
15. Repression of the promoter activity mediated by liver receptor homolog-1 through interaction with ku proteins.
Ohno M; Komakine J; Suzuki E; Nishizuka M; Osada S; Imagawa M
Biol Pharm Bull; 2010; 33(5):784-91. PubMed ID: 20460755
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide analysis of hepatic LRH-1 reveals a promoter binding preference and suggests a role in regulating genes of lipid metabolism in concert with FXR.
Chong HK; Biesinger J; Seo YK; Xie X; Osborne TF
BMC Genomics; 2012 Feb; 13():51. PubMed ID: 22296850
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.
Solomon IH; Hager JM; Safi R; McDonnell DP; Redinbo MR; Ortlund EA
J Mol Biol; 2005 Dec; 354(5):1091-102. PubMed ID: 16289203
[TBL] [Abstract][Full Text] [Related]
18. Comparison of activity, structure, and dynamics of SF-1 and LRH-1 complexed with small molecule modulators.
Cato ML; D'Agostino EH; Spurlin RM; Flynn AR; Cornelison JL; Johnson AM; Fujita RA; Abraham SM; Jui NT; Ortlund EA
J Biol Chem; 2023 Aug; 299(8):104921. PubMed ID: 37328104
[TBL] [Abstract][Full Text] [Related]
19. Liver receptor homolog-1, an emerging metabolic modulator.
Lee YK; Moore DD
Front Biosci; 2008 May; 13():5950-8. PubMed ID: 18508634
[TBL] [Abstract][Full Text] [Related]
20. Dual mechanisms for repression of the monomeric orphan receptor liver receptor homologous protein-1 by the orphan small heterodimer partner.
Lee YK; Moore DD
J Biol Chem; 2002 Jan; 277(4):2463-7. PubMed ID: 11668176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
